AtriCure (NASDAQ: ATRC) is set to announce its financial results for the third quarter of 2024 on Tuesday 29th October 2024. This highly anticipated announcement is scheduled to take place after market close. Investors will have the opportunity to learn more about the company's performance during the quarter.
the establishment is projected to announce an estimated per share $0.19 loss for the quarter, as predicted by financial analysts on Wall Street. Moreover, the company is expected to disclose a total revenue of $112.25 million for this period.
When examining the corresponding quarter from the previous year, the company's earnings report highlighted a per-share loss of $0.2. This results was derived from the company's total revenue, which reached an impressive $98.29 million during same quarter.
Analysts forecasting the company's performance for this year have been made public. The estimated total revenue is about $458.11 million. They also predict that throughout the course of the fiscal year, the business will make about loss of $0.79 per share.
| Period | EPS Actual |
EPS Growth* |
Revenue Actual |
Revenue Growth* |
|---|---|---|---|---|
| Historical Earnings Insight | ||||
| Q2 2024 | $-0.17 | -41.7% | 116.27 M | +15.2% |
| Q1 2024 | $-0.25 | -8.7% | 108.85 M | +16.4% |
| Q4 2023 | $-0.21 | -133.3% | 106.54 M | +21.0% |
| Q3 2023 | $-0.20 | +25.9% | 98.29 M | +18.1% |
| Q2 2023 | $-0.12 | +62.5% | 100.92 M | +19.4% |
| *Growth on year-over-year basis | ||||
In addition, The firm will review the third quarter financial results on 29th October 2024 at 04:30 PM eastern time, in a conference call with public.
AtriCure (ATRC) experienced a trading range of $27.64 to $28.90, along with a total volume of 571.60 thousand shares during the day. The stock concluded Friday's regular trading session at $27.93, demonstrating decrease of 2.62 percent.
